Author:
Lu Guo-Liang,Tong Amy S.T.,Conole Daniel,Sutherland Hamish S.,Choi Peter J.,Franzblau Scott G.,Upton Anna M.,Lotlikar Manisha U.,Cooper Christopher B.,Denny William A.,Palmer Brian D.
Funder
United States Agency for International Development
Bill and Melinda Gates Foundation
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference21 articles.
1. WHO Global Tuberculosis Report 2019 (https://www.who.int/tb/publications/global_report/en/): accessed 2nd July 2020.
2. A Diarylquinoline Drug Active on the ATP Synthase of
Mycobacterium tuberculosis
3. On behalf of the TMC207-C209 study group;Pym;Eur. Respir. J.,2016
4. Global Alliance for TB Drug Development website (https://www.tballiance.org/portfolio/compound/tbaj-876-diarylquinoline); accessed 2nd July 2020.
5. 3,5-Dialkoxypyridine analogs of bedaquiline are potent antitubercular agents with minimal inhibition of the hERG channel;Sutherland;Bioorg Med Chem,2019
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献